Benchmarking infrastructure for cancer control in Commonwealth countries: a population-based observational study - 01/07/25
, Cecilia Sousa, MD c, Rifat Atun, ProfFRCP a, b, dSummary |
Background |
Health systems in the Commonwealth perform suboptimally in relation to cancer control. We applied a proprietary health system analysis framework to benchmark cancer control infrastructure and explore the implications for health systems to enhance the cancer response.
Methods |
In this multinational, population-based observational study across all 56 Commonwealth countries, we analysed data across five health system infrastructure elements: imaging diagnostics (mammography), imaging diagnostics (CT), treatment (radiation oncology), treatment (surgery), and health-care providers (hospitals). Five indicators were prioritised on the basis of the availability of timely, comprehensive, consistent, standardised, and reliable data to assess the five elements and collectively provide a tracer for health system infrastructure availability for cancer control, the primary study endpoint. We collected data and conducted analyses to benchmark the availability of infrastructure against established international targets.
Findings |
The study was conducted between July 1, 2024, and Nov 25, 2024. The countries comprising the Commonwealth fall short of established targets for cancer control infrastructure, with diagnostics (mammography) as the only exception. The most substantial deficits are in imaging diagnostics (CT), health-care facilities, and surgery, particularly in Africa (13–24 times lower than the international targets), Asia (1–4 times), low-income countries (13–46 times), lower-middle-income countries (6–43 times), and non-small states (5–30 times). Major inequities in infrastructure availability are evident and the greatest disparities were observed in radiation oncology, with variations of 62 times by country income group, 47 times by world region, and eight times by state size.
Interpretation |
Our analysis reveals major infrastructure deficits in the Commonwealth, which could directly affect the availability of effective, efficient, equitable, and responsive screening, diagnosis, and treatment, leading to suboptimal patient outcomes. Infrastructure expansion could be informed by collecting timely, reliable, and standardised data on infrastructure as part of a Cancer Control Data Observatory, extending the Commonwealth pooled procurement mechanism, and fostering strategic public–private partnerships.
Funding |
Harvard University.
Le texte complet de cet article est disponible en PDF.Plan
Vol 26 - N° 7
P. 924-935 - juillet 2025 Retour au numéro
Article précédent
- Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group
- Katie M O’Brien, Melissa G House, Mandy Goldberg, Michael E Jones, Clarice R Weinberg, Amy Berrington de Gonzalez, Kimberly A Bertrand, William J Blot, Jessica Clague DeHart, Fergus J Couch, Montserrat Garcia-Closas, Graham G Giles, Victoria A Kirsh, Cari M Kitahara, Woon-Puay Koh, Hannah Lui Park, Roger L Milne, Julie R Palmer, Alpa V Patel, Thomas E Rohan, Minouk J Schoemaker, Anthony J Swerdlow, Lauren R Teras, Celine Vachon, Kala Visvanathan, Jian-Min Yuan, Wei Zheng, Hazel B Nichols, Dale P Sandler
- Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
- Alison C Tree, Victoria Hinder, Andrew Chan, Shaun Tolan, Peter Ostler, Hans van der Voet, Kiran Kancherla, Andrew Loblaw, Olivia Naismith, Suneil Jain, Alexander Martin, Derek Price, Douglas Brand, William Chu, Aileen Duffton, Paul Kelly, Brian O’Neill, John Staffurth, Giuseppe Sasso, Julia Pugh, Georgina Manning, Stephanie Brown, Stephanie Burnett, Clare Griffin, Emma Hall, Nicholas van As, PACE Investigators, Imtiaz Ahmed, Mark Beresford, Thomas Bird, Jennifer Branagan, Patryk Brulinski, Philip Camilleri, Ananya Choudhury, Prantik Das, Omar Din, Daniel Ford, Victoria Ford, John Frew, Peter Jenkins, Bartlomiej Kurec, Carolynn Lamb, Eric Lee, Anna Lydon, Maria Martinou, John McGrane, Alina Mihai, Vinod Mullassery, Sarah Needleman, Ashok Nikapota, Nikhil Oommen, Sophie Otter, Miguel Panades, Dominique Parslow, Rachel Pearson, Rakeshkumar K. Raman, Mausam Singhera, Yae-Eun Suh, Aravindhan Sundaramurthy, Jacob Tanguay, Kamalram Thippu Jayaprakash, Hans Van Der Voet, Salil Vengalil, Ramachandran Venkitaraman, Robert Wade, Georgina Walker, Paula Wells
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?